179 related articles for article (PubMed ID: 28681506)
1. Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial.
Ellis AK; Tsitoura DC; Quint D; Powley W; Lee LA
Clin Exp Allergy; 2017 Sep; 47(9):1193-1203. PubMed ID: 28681506
[TBL] [Abstract][Full Text] [Related]
2. Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.
Siddall H; Quint D; Pandya H; Powley W; Shabbir S; Hohlfeld JM; Singh D; Lee L
PLoS One; 2020; 15(11):e0240964. PubMed ID: 33166307
[TBL] [Abstract][Full Text] [Related]
3. Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement.
Tsitoura D; Ambery C; Price M; Powley W; Garthside S; Biggadike K; Quint D
Clin Pharmacol Ther; 2015 Oct; 98(4):369-80. PubMed ID: 26044169
[TBL] [Abstract][Full Text] [Related]
4. GSK2245035, a TLR7 agonist, Does Not Increase Pregnancy Loss in Cynomolgus Monkeys.
Posobiec LM; Hillegas AE; Baker A; Phadnis-Moghe AS; Maier CC; Stanislaus DJ; Bray M; Price MA
J Reprod Immunol; 2021 Feb; 143():103242. PubMed ID: 33212303
[TBL] [Abstract][Full Text] [Related]
5. Biological effects and clinical efficacy of a topical Toll-like receptor 7 agonist in seasonal allergic rhinitis: a parallel group controlled phase IIa study.
Greiff L; Ahlström-Emanuelsson C; Alenäs M; Almqvist G; Andersson M; Cervin A; Dolata J; Lindgren S; Mårtensson A; Young B; Widegren H
Inflamm Res; 2015 Nov; 64(11):903-15. PubMed ID: 26342289
[TBL] [Abstract][Full Text] [Related]
6. Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions.
Corren J; Rachelefsky G; Spector S; Schanker H; Siegel S; Holton D; Karcher K; Travers S
J Allergy Clin Immunol; 1999 Apr; 103(4):574-80. PubMed ID: 10200003
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitis.
Horak F; Puri KD; Steiner BH; Holes L; Xing G; Zieglmayer P; Zieglmayer R; Lemell P; Yu A
J Allergy Clin Immunol; 2016 Jun; 137(6):1733-1741. PubMed ID: 26915677
[TBL] [Abstract][Full Text] [Related]
8. Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis.
Greiff L; Cervin A; Ahlström-Emanuelsson C; Almqvist G; Andersson M; Dolata J; Eriksson L; Högestätt E; Källén A; Norlén P; Sjölin IL; Widegren H
Respir Res; 2012 Jun; 13(1):53. PubMed ID: 22726593
[TBL] [Abstract][Full Text] [Related]
9. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma.
Biggadike K; Ahmed M; Ball DI; Coe DM; Dalmas Wilk DA; Edwards CD; Gibbon BH; Hardy CJ; Hermitage SA; Hessey JO; Hillegas AE; Hughes SC; Lazarides L; Lewell XQ; Lucas A; Mallett DN; Price MA; Priest FM; Quint DJ; Shah P; Sitaram A; Smith SA; Stocker R; Trivedi NA; Tsitoura DC; Weller V
J Med Chem; 2016 Mar; 59(5):1711-26. PubMed ID: 26861551
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C
J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis.
Badorrek P; Hohlfeld JM; Krug N; Joshi A; Raut A
Ann Allergy Asthma Immunol; 2015 Oct; 115(4):325-329.e1. PubMed ID: 26272281
[TBL] [Abstract][Full Text] [Related]
13. Safety of the intranasal toll-like receptor 4 agonist CRX-675 in allergic rhinitis.
Casale TB; Kessler J; Romero FA
Ann Allergy Asthma Immunol; 2006 Oct; 97(4):454-6. PubMed ID: 17069098
[TBL] [Abstract][Full Text] [Related]
14. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.
Bauer RN; Xie Y; Beaudin S; Wiltshire L; Wattie J; Muñoz C; Alsaji N; Oliveria JP; Ju X; MacLean J; Sommer DD; Keith PK; Satia I; Cusack RP; O'Byrne PM; Sperinde G; Hokom M; Li O; Banerjee P; Chen C; Staton T; Sehmi R; Gauvreau GM
Clin Exp Allergy; 2023 Nov; 53(11):1187-1197. PubMed ID: 37794659
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and tolerability of two novel H(1)/H(3) receptor antagonists in seasonal allergic rhinitis.
Daley-Yates P; Ambery C; Sweeney L; Watson J; Oliver A; McQuade B
Int Arch Allergy Immunol; 2012; 158(1):84-98. PubMed ID: 22212854
[TBL] [Abstract][Full Text] [Related]
19. Blood and nasal epigenetics correlate with allergic rhinitis symptom development in the environmental exposure unit.
North ML; Jones MJ; MacIsaac JL; Morin AM; Steacy LM; Gregor A; Kobor MS; Ellis AK
Allergy; 2018 Jan; 73(1):196-205. PubMed ID: 28755526
[TBL] [Abstract][Full Text] [Related]
20. Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.
Valero A; Serrano C; Bartrá J; Izquierdo I; Muñoz-Cano R; Mullol J; Picado C
J Investig Allergol Clin Immunol; 2009; 19(6):488-93. PubMed ID: 20128424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
